Perkins Value Plus Income Fund

2 / 5 Stars
4 4 5 4 1
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
3 / 5 Stars
C (Hold)

#55 in Moderate Allocation

U.S. News evaluated 247 Moderate Allocation Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Janus funds

See full Moderate Allocation rankings

See more fund rankings


The fund has returned 10.86 percent over the past year, and 8.86 percent over the past three years.

Trailing Returns Updated 02.28.2014
Year to date 1.9%
1 Year 10.9%
3 Years (Annualized) 8.9%
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more JPVAX performance


The investment seeks capital appreciation and current income. The fund pursues its investment objective by normally investing 40-60% of its assets in equity securities selected primarily for capital appreciation and investing the remainder in fixed-income securities and cash equivalents. It may invest in foreign equity and debt securities, which may include investments in emerging markets. The fund may also invest its assets in derivatives, which are instruments that have a value derived from, or directly linked to, an underlying asset, such as equity securities, fixed-income securities, commodities, currencies, interest rates, or market indices.


Fees are Above Average compared to funds in the same category.
Perkins Value Plus Income Fund has an expense ratio of 1.01 percent.

See more JPVAX fees


Risk is Low compared to funds in the same category according to Morningstar.

See more JPVAX risk